Cantargia Ownership

CANTA Stock  SEK 1.77  0.10  5.35%   
Cantargia holds a total of 166.99 Million outstanding shares. 30% of Cantargia AB outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cantargia AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cantargia Stock Ownership Analysis

About 34.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.11. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cantargia AB recorded a loss per share of 4.11. The entity had not issued any dividends in recent years. The firm had 1615:1344 split on the 22nd of July 2022. Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people. For more info on Cantargia AB please contact Goran Forsberg at 46 4 62 75 62 60 or go to https://www.cantargia.com.

Cantargia Outstanding Bonds

Cantargia issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cantargia AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cantargia bonds can be classified according to their maturity, which is the date when Cantargia AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cantargia Stock Analysis

When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.